ET WASHINGTON—U.0% in February from the prior month to a seasonally adjusted annual rate of 1.
S.economy March 16, 2018 9:17 a.
business prices rose in February, a sign of modest inflation pressure.The producer-price index, a measure of the prices businesses charge for their goods and services, increased 0.
“Everyone is kind of preparing, loading the shotgun for another strong month,” said Diogo Lobo, chief executive of NorthPoint Logistics in Kansas City.That bested last February’s imports by 32.
9% in February according to data provided by S&P; Global Market Intelligence after releasing fourth quarter earnings that disappointed investors at the end of the month.So whatCabometyx sales more than doubled year over year, which isn't too shabby, but sales were flat quarter over quarter, worrying investors about the trajectory of the launch.
Dow Jones, a News Corp companyNews Corp is a network of leading companies in the worlds of diversified media, news, education, and information services The report’s index of energy prices rose 0.1%, as gasoline and fuel oil costs declined March 13, 2018 8:35 a.
Dow Jones, a News Corp companyNews Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Most of the indicators in Conference Board’s index made positive contributions March 12, 2018 10:35 a.ET The Conference Board Employment Trends Index rose in February as most of the indicators the index factors in made positive contributions.
The February jobs report is out and it’s a huge beat.The February jobs report beat expectations, boosting markets and confirming that the U.
ET OTTAWA—Canada’s unemployment rate edged down in February to a 10-year low, and the economy added jobs after a steep decline in the previous month.Market expectations were set at a 21,000 advance in employment, according to economists at Royal Bank of Canada.
At 4.economy can run strong without overheating and forcing the Federal Reserve to slam its brakes on the expansion with aggressive interest-rate increases.
What happenedShares of Chesapeake Energy Corp.(NYSE: CHK) tumbled last month, falling nearly 19% even though the natural gas company posted better-than-expected fourth-quarter results and production guidance for 2018.
What happenedShares of Chesapeake Energy Corporation (NYSE: CHK) tumbled last month, falling nearly 19% even though the company posted better-than-expected fourth-quarter results and production guidance for 2018.So whatChesapeake Energy sold off after unveiling its fourth-quarter production update in early February, hitting its lowest level in two years after posting production volumes that came in below expectations.
What happenedShares of Crispr Therapeutics AG (NASDAQ: CRSP), a pre-clinical-stage biotech, rose 23.Offhand comments from the management team at Gilead Sciences, Inc.
The stock's slide stands in stark contrast to the price of gold's 2.So what Whereas the company, in fiscal 2016, exceeded gold production guidance, it failed to achieve the same feat in fiscal 2017.
The real estate sector performs relatively in-line with the wider economy.Prosperous periods bring about high growth and inflation, leading to strong returns in real estate investments.
Industrial names generally suffer from deep cyclicality which can affect companies operating in areas ranging from machinery to aerospace to construction.As such, the position a company has relative to the economic cycle drives its level of profitability.
The University of Michigan on Friday said its consumer-sentiment index was 99.9 in February, up from 95.
But Exxon's laggard showing could present a buying opportunity, as well, if you have a value bent.Here are some quick takes on what you need to know about this trio of top oil stocks to buy in February, spanning a wide range of investment opportunities.
With that in mind, we asked three of our contributing investors to spotlight their pick for a top dividend stock to buy this month.A big pharma turnaround storyKeith Speights (Pfizer): One dividend stock that I like more in February than I did only a few weeks ago is Pfizer.